Angle‑closure glaucoma - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Angle‑Closure Glaucoma – Comprehensive Medical Guide

Angle‑Closure Glaucoma – A Complete Patient Guide

Overview

Angle‑closure glaucoma (ACG), also called acute or chronic primary angle‑closure glaucoma, is a type of secondary glaucoma in which the drainage angle of the eye becomes suddenly or gradually blocked. This prevents aqueous humor – the fluid that nourishes the front part of the eye – from exiting the eye, leading to a rapid rise in intraocular pressure (IOP). If untreated, the elevated pressure can damage the optic nerve and cause irreversible vision loss.

Who it affects: ACG is far less common than the open‑angle form, but it tends to affect people of Asian descent, older adults, and females more frequently.

  • Global prevalence of angle‑closure glaucoma: ~0.5% of the population, compared with ~2‑3% for open‑angle glaucoma.[1]
  • In East Asian countries (China, Japan, Korea) the prevalence rises to 1.5‑2% and accounts for up to 30% of all glaucoma cases.[2]
  • Women are about 1.5‑2 times more likely to develop angle‑closure than men, possibly due to shallower anterior chambers.[3]
  • Risk increases sharply after age 50; the median age of an acute attack is 60‑70 years.[4]

Symptoms

Symptoms can be sudden (acute attack) or gradual (chronic angle‑closure). Recognizing the full spectrum helps patients seek timely care.

Acute angle‑closure (medical emergency)

  • Severe eye pain – often described as a deep, throbbing ache.
  • Headache – typically frontal or behind the eye.
  • Redness – the sclera (white of the eye) looks blood‑shot.
  • Blurred or haloes around lights – especially noticeable at night.
  • Nausea and vomiting – due to the intense pain and autonomic response.
  • Mid‑dilated, non‑reactive pupil – the affected eye’s pupil may be larger and unresponsive to light.
  • Reduced visual acuity – sudden loss of sharpness, sometimes described as “foggy vision.”

Chronic or sub‑acute angle‑closure (insidious)

  • Gradual peripheral vision loss (tunnel vision) that may go unnoticed for years.
  • Mild eye discomfort or intermittent blurred vision.
  • Occasional halos around lights, especially in low‑light settings.
  • Small fluctuations in IOP that cause occasional eye redness.
  • Patients may be asymptomatic until optic nerve damage is measurable.

Causes and Risk Factors

Angle‑closure glaucoma usually results from an anatomic predisposition that makes the angle between the iris and cornea “narrow.” When the iris pushes forward, it blocks the trabecular meshwork – the eye’s drainage system.

Primary mechanisms

  • Pupillary block – The flow of aqueous humor from the posterior to the anterior chamber is impeded at the pupil, causing the iris to bow forward (called “iris bombe”).
  • Plateau‑iris configuration – The peripheral iris lies anteriorly even without pupillary block, narrowing the angle.
  • Lens thickening (cataract progression) – An aging lens pushes the iris forward.

Key risk factors

  • Age ≥ 50 years – Lens growth and reduced anterior chamber depth.
  • Female sex – Hormonal influences and generally shallower chambers.
  • Asian ancestry – Higher prevalence of narrow angles.
  • Family history of glaucoma – Genetic predisposition.
  • Hyperopia (farsightedness) – Shorter eyeball length concentrates structures.
  • Medications that dilate pupils – Anticholinergics, antihistamines, certain antidepressants, and some phenylephrine‑containing eye drops.
  • Systemic conditions – Diabetes, hypertension, and certain connective‑tissue disorders can increase risk.
  • Previous ocular surgery – Especially procedures that affect the anterior segment (e.g., laser iridotomy failure).

Diagnosis

Prompt, accurate diagnosis is essential to prevent permanent vision loss.

Clinical examination

  1. Visual acuity testing – Determines baseline clarity of vision.
  2. Slit‑lamp biomicroscopy – Allows the clinician to examine the cornea, anterior chamber depth, and pupil reaction.
  3. Gonioscopy – The gold‑standard test; a special lens visualizes the drainage angle to confirm narrowing or closure.
  4. Tonometry – Measures intraocular pressure; values > 21 mmHg raise suspicion, but acute attacks often exceed 30‑40 mmHg.
  5. Fundus examination – Evaluates optic nerve head for cupping or damage.

Imaging and ancillary tests

  • Anterior segment optical coherence tomography (AS‑OCT) – Provides cross‑sectional images of the angle.
  • Ultrasound biomicroscopy (UBM) – High‑resolution ultrasound that visualizes structures hidden behind the iris.
  • Visual field testing (perimetry) – Detects peripheral vision loss.
  • Specular microscopy – Assesses corneal endothelial health, useful before surgery.

Treatment Options

Treatment goals are to lower IOP quickly, relieve the blockage, and prevent future attacks.

Emergency (acute) management

  1. Topical ocular hypotensive agents – Pilocarpine 2% (to constrict the pupil), apraclonidine, or brimonidine.
  2. Systemic carbonic anhydrase inhibitors – Oral acetazolamide 250‑500 mg; IV acetazolamide if oral route unavailable.
  3. Hyperosmotic agents – Oral glycerol or IV mannitol to rapidly draw fluid out of the eye.
  4. Immediate laser peripheral iridotomy (LPI) – A tiny hole is created in the peripheral iris using a Nd:YAG or diode laser, bypassing the pupillary block.
  5. Surgical iridectomy (if laser fails) – Surgical removal of a piece of the iris to open the angle.

Long‑term management

  • Laser peripheral iridotomy (prophylactic) – Often performed even in the opposite eye that has a narrow angle but no attack.
  • Lens extraction (cataract surgery) – Removing a thickened lens deepens the anterior chamber, commonly resolves angle closure in older adults.[5]
  • Medications – If IOP remains elevated after iridotomy:
    • Beta‑blockers (timolol)
    • Prostaglandin analogues (latanoprost)
    • Alpha‑agonists (brimonidine)
    • Carbonic anhydrase inhibitors (brinzolamide)
  • Filtering surgeries – Trabeculectomy or tube shunt implantation for refractory cases.

Lifestyle & supportive care

  • Avoid medications that dilate the pupil unless prescribed.
  • Stay well‑hydrated but avoid excessive fluid intake that could raise IOP abruptly.
  • Use protective eyewear to prevent trauma.

Living with Angle‑closure Glaucoma

Chronic disease management is similar to other forms of glaucoma, emphasizing regular monitoring and eye‑health habits.

Daily management tips

  • Adhere to medication schedules – Missing doses can cause IOP spikes.
  • Attend all follow‑up appointments – Usually every 3‑6 months, or more often after a recent procedure.
  • Self‑monitoring – Some patients use home tonometers; discuss suitability with your ophthalmologist.
  • Protect your eyes from bright light – Sunglasses reduce pupillary dilation.
  • Stay active – Regular aerobic exercise modestly lowers IOP.
  • Manage systemic health – Keep blood pressure, diabetes, and cholesterol under control.

Psychological aspects

Living with a vision‑threatening condition can cause anxiety. Support groups, counseling, and patient‑education resources (Glaucoma Foundation, AAO) are valuable.

Prevention

Because the anatomical predisposition cannot be altered, prevention focuses on early detection and avoiding triggers.

  • Screen high‑risk individuals – People over 50 of Asian descent or with a family history should have a baseline gonioscopy.
  • Prophylactic laser iridotomy – Recommended when a narrow angle is identified before any attack.
  • Medication review – Inform all prescribers of your glaucoma status; avoid over‑the‑counter decongestants or antihistamines that cause dilation.
  • Regular eye exams – At least yearly for those with risk factors; sooner after any eye surgery or trauma.

Complications

If left untreated, angle‑closure glaucoma can lead to serious, irreversible outcomes.

  • Permanent optic‑nerve damage – Leads to irreversible visual field loss.
  • Complete blindness – Rare but possible after repeated acute attacks with very high IOP.
  • Corneal endothelial decompensation – High pressure damages corneal cells, causing edema and vision blur.
  • Secondary ocular hypertension – Persistent elevation of IOP even after angle opening.
  • Psychosocial impact – Loss of independence, driving restrictions, and increased fall risk.

When to Seek Emergency Care

Warning signs of an acute angle‑closure attack:
  • Sudden, severe eye pain that does not improve
  • Rapidly worsening headache (often frontal)
  • Redness of the eye with a mid‑dilated pupil that does not respond to light
  • Seeing halos or colored rings around lights
  • Nausea, vomiting, or feeling faint
  • Sudden loss of vision or blurry vision

If any of these symptoms appear, go to the nearest emergency department or call emergency services (e.g., 911) immediately. Delay can result in permanent vision loss.

References

  1. J. Wang et al., “Prevalence and Risk Factors of Angle‑Closure Glaucoma in Asia,” Ophthalmology, 2020.
  2. World Health Organization, “Glaucoma Fact Sheet,” 2021.
  3. Centers for Disease Control and Prevention, “Vision Health Initiative: Glaucoma,” 2022.
  4. Mayo Clinic, “Angle‑closure glaucoma: Symptoms and causes,” accessed May 2026.
  5. Cleveland Clinic, “Angle‑closure glaucoma: Treatment options,” accessed May 2026.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References